FHA
AGIO icon

Flagship Harbor Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Flagship Harbor Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20
Closed – – 588
2020
Q3 		$0 Hold
20
– – ﹤0.01% 1900
2020
Q2 		$1K Hold
20
– – ﹤0.01% 1870
2020
Q1 		$1K Hold
20
– – ﹤0.01% 1710
2019
Q4 		$1K Hold
20
– – ﹤0.01% 1779
2019
Q3 		$0 Hold
20
– – ﹤0.01% 1823
2019
Q2 		$0 Hold
20
– – ﹤0.01% 1847
2019
Q1 		$1K Hold
20
– – ﹤0.01% 1732
2018
Q4 		$0 Hold
20
– – ﹤0.01% 1821
2018
Q3 		$2K Hold
20
– – ﹤0.01% 1878
2018
Q2 		$1K Buy
+20
New +$1.74K ﹤0.01% 1913

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Flagship Harbor Advisors's AGIO Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 20 shares.

Flagship Harbor Advisors first reported a position in AGIO in Q2 2018 and held it in 10 quarters. The position peaked at $2K in Q3 2018. 201 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 20 Agios Pharmaceuticals shares in Q4 2020.
  • Flagship Harbor Advisors first reported a position in Agios Pharmaceuticals in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Agios Pharmaceuticals position peaked at $2K in Q3 2018.
  • 201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.